New Delhi: The government can immediately provide a big boost to export covid vaccines with the state and UTS which have more than 22 crore doses that are not diautil, the official official source said.
While the central recently supplied to Covax, now also consider allowing commercial export.
The Ministry of Health has given permission to the Serum Institute to export a dose of Crore Covishield through Covax.
India has also continued supply to Myanmar, Nepal, Bangladesh and Iran, almost 8 months after it stopped exports.
“Vaccine production increases rapidly.
The state will soon have a supply of surplus.
What will we do with it if we do not allow export?” The source said.
Thirty crore doses have been delivered in November, while only 8.8 doses of Crore have been given in the month so far.
Vax Bio E can appear for a nod of emergency use in December December, inventory is expected to increase further.
About 31 doses of crore from Covishield and Covaxin are scheduled to be accepted in December, while two doses of two crore from Zycov-D Cadila Healthcare are also expected at the end of the year.
In addition, new jabs such as Corbevax e biologically are expected to emerge to authorize emergency use in December.
On the other hand, consumption patterns are not expected to witness a significant increase with more than 81% adult populations that have been covered with at least the first dose.
This also means the new vaccine demand will be very limited, unless they are approved and used as a third dose or for use in children.
While vaccination is now mostly driven by the second dose coverage, it will move according to the schedule.
About 42% of the adult population in this country is now fully vaccinated with both doses.
However, there is still a big demand for vaccines in the world, especially for Jab produced in India because they tend to be far more cost effective than globally available.
“There are many countries waiting for vaccines.
There are 195 countries in the world and only 40 of them have reached 75% of vaccination coverage,” said the source.